LWM Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,702
Closed -$394K 84
2025
Q3
$394K Sell
1,702
-30
-2% -$6.11K 0.23% 70
2025
Q2
$321K Sell
1,732
-37
-2% -$6.88K 0.22% 77
2025
Q1
$370K Hold
1,769
0.26% 70
2024
Q4
$315K Hold
1,769
0.22% 75
2024
Q3
$349K Buy
1,769
+199
+13% +$37.1K 0.26% 71
2024
Q2
$269K Sell
1,570
-197
-11% -$32.6K 0.23% 69
2024
Q1
$322K Buy
1,767
+71
+4% +$12.2K 0.26% 70
2023
Q4
$263K Buy
1,696
+18
+1% +$2.62K 0.23% 70
2023
Q3
$250K Buy
1,678
+63
+4% +$9.25K 0.27% 63
2023
Q2
$218K Sell
1,615
-238
-13% -$34.9K 0.23% 72
2023
Q1
$295K Buy
1,853
+118
+7% +$18K 0.32% 64
2022
Q4
$280K Sell
1,735
-1,527
-47% -$234K 0.31% 63
2022
Q3
$438K Buy
3,262
+476
+17% +$68.3K 0.5% 59
2022
Q2
$427K Buy
2,786
+1,355
+95% +$207K 0.51% 62
2022
Q1
$232K Buy
+1,431
New +$208K 0.29% 101

Other funds holding ABBV

LWM Advisory Services's ABBV Position: Q4 2025 in Review

LWM Advisory Services sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 1,702 shares — an estimated $394K sold.

LWM Advisory Services first reported a position in ABBV in Q1 2022 and held it in 15 quarters. The position peaked at $438K in Q3 2022. 4,148 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • LWM Advisory Services reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • LWM Advisory Services sold 1,702 AbbVie shares in Q4 2025, an estimated $394K.
  • LWM Advisory Services first reported a position in AbbVie in Q1 2022 and held it in 15 quarters.
  • LWM Advisory Services's AbbVie position peaked at $438K in Q3 2022.
  • 4,148 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on LWM Advisory Services's 13F filing for Q4 2025, filed 12 Feb 2026.